Free Cancer Report

Book Appointment with Dr Mohammed Ibrahim in Chennai

Dr Mohammed Ibrahim

Surgical Oncologist

11 Years Exp. Chennai

Head And Neck Cancer

HCG Cancer Centre, Chennai

11 years of experience



About Dr Mohammed Ibrahim:

Dr Mohammed Ibrahim graduated from a prestigious Medical College in Chennai and then went on to pursue MS in General Surgery from a reputed Medical College in Chennai, where he took special interest in laparoscopic surgeries and other endoscopic procedures. He then went on to complete his MRCS degree from the Royal College of Surgeons, Edinburgh, UK. He also completed his Diploma in DNB - General Surgery - from New Delhi. He is trained in major respective surgeries in cancers of Head and Neck, Thyroid, Breast, Gastro-intestinal, Uro-Gynecological and musculo-skeletal systems and also in various oncoplastic and aesthetis plastic reconstruction procedures after cancer surgeries. Dr Ibrahim has many awards and medals to his credit. He has presented various papers and posters on Surgical Oncology, in various National and International Conferences and journals. He is an active member in various academic bodies, including the Association of Surgeons of India (ASI), Indian Royal College of Surgeons, Edinburgh, UK, and the Society of Surgical Oncology (SSO), Illinois, US. He has performed various major onco-surgical procedures for breast, gastrointestinal, colorectal, urogynecological and musculoskeletal malignancies. It is noteworthy that he has devised a special technique for chemo port insertion, for patients who require Chemotherapy.


MBBS from The Tamil Nadu Dr. M.G.R. Medical University (TNMGRMU), 2004 MS (General Surgery) from Madras Medical College, Chennai, 2008 DNB (Surgical Oncology) from Regional Cancer Centre MRCS Royal College of Surgeons, Edinburgh, UK DNB (General Surgery) from National Board of Examinations


2012 - Present Chief Consultant (Surgical Oncology) at HCG - Kauvery Hospitals 2009 - 2012 Consultant at Regional Cancer Center, Trivandrum


Indian Association of Surgical Oncology (IASO) Association of Minimal Access Surgeons of India (AMASI) Association of Colo-Rectal Surgeons of India (ACRSI) Association of Breast Surgeons of India (ABSI) Association of Surgeons of India (ASI) Membership of the Royal College of Surgeons (MRCS) Society of Surgical Oncology (SSO)

Areas of interest:

Head And Neck Cancer, Thyroid Cancer, Breast Cancer, Gastrointestinal (GI) Cancer, Urethral Cancer, Muscoskeletal Sarcoma.

Research publications:

Ng, Terry & Tu, Megan & Ibrahim, Mohammed & Basulaiman, Bassam & McGee, Sharon & Srikanthan, Amirrtha & Fernandes, Ricardo & Vandermeer, Lisa & Stober, Carol & Sienkiewicz, Marta & Jeong, Ahwon & Saunders, Deanna & Awan, Arif & Hutton, Brian & Clemons, Mark. (2020). Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review. Supportive Care in Cancer. Ng, Terry & Tu, Megan & Ibrahim, Mohammed & Basulaiman, Bassam & McGee, Sharon & Srikanthan, Amirrtha & Fernandes, Ricardo & Vandermeer, Lisa & Stober, Carol & Sienkiewicz, Marta & Jeong, Ahwon & Saunders, Deanna & Awan, Arif & Hutton, Brian & Clemons, Mark. (2020). Efficacy and toxicity of extending bone modifying agents beyond two years for bone metastases in breast or castrate-resistant prostate cancer patients: A systematic review.. Journal of Clinical Oncology. 38. e24083-e24083. Clemons, Mark & Fergusson, Dean & Joy, Anil & Meza-Junco, Judith & Hiller, Julie & Mackey, John & Zhu, Xiaofu & Ibrahim, Mohammed & Basulaiman, Bassam & Awan, Arif & Sienkiewicz, Marta & Vandermeer, Lisa & Pitre, Lacey & Nixon, Nancy & Hutton, Brian & Pond, Gregory & Hilton, John. (2020). A multicenter study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of taxotere/cyclophosphamide-induced febrile neutropenia in patients with early-stage breast cancer.. Journal of Clinical Oncology. 38. 7001-7001. Clemons, M. & Fergusson, D. & Simos, D. & Mates, M. & Robinson, A. & Califaretti, Nadia & Zibdawi, L. & Bahl, M. & Raphael, J. & Ibrahim, Mohammed & Fernandes, Roland & Pitre, L. & Aseyev, Olexiy & Stober, C. & Vandermeer, L. & Saunders, D. & Hutton, Brian & Mallick, R. & Pond, Gregory & Hilton, J.. (2020). A multi-centre, randomised trial comparing schedules of G-CSF (filgrastim) administration for primary prophylaxis of chemotherapy-induced febrile neutropenia in early stage breast cancer. Annals of Oncology. 31. Canonici, Alexandra & Browne, Alacoque & Ibrahim, Mohammed & Fanning, Kevin & Roche, Sandra & Conlon, Neil & O'Neill, Fiona & Meiller, Justine & Cremona, Mattia & Morgan, Clare & Hennessy, Bryan & Eustace, Alex & Solca, F. & O'Donovan, Norma & Crown, John. (2020). Combined targeting EGFR and SRC as a potential novel therapeutic approach for the treatment of triple negative breast cancer. Therapeutic Advances in Medical Oncology. 12. 175883591989754. Robertson, SJ & Ibrahim, Mohammed & Stober, Carol & Hilton, John & Kos, Zuzana & Mazzarello, Sasha & Ramsay, Tim & Fergusson, Dean & Vandermeer, Lisa & Mallick, Ranjeeta & Arnaout, Angel & Dent, Susan & Segal, Roanne & Sehdev, Sandeep & Gertler, Stan & Hutton, Brian & Clemons, Mark. (2019). Does integration of Magee equations into routine clinical practice affect whether oncologists order the Oncotype DX test? A prospective randomized trial. Journal of Evaluation in Clinical Practice. 25. Clemons, Mark & Mazzarello, Sasha & Hilton, John & Joy, Anil & Price-Hiller, Julie & Zhu, Xiaofu & Verma, Shailendra & Kehoe, Anne & Ibrahim, Mohammed & Sienkiewicz, Marta & Stober, Carol & Vandermeer, Lisa & Hutton, Brian & Mallick, Ranjeeta & Fergusson, Dean. (2018). Feasibility of using a pragmatic trials model to compare two primary febrile neutropenia prophylaxis regimens (ciprofloxacin versus G-CSF) in patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer (REaCT-TC). Supportive Care in Cancer. 27. LeVasseur, Nathalie & Stober, C & Ibrahim, Mohammed & Gertler, S & Hilton, J & Robinson, A & Mcdiarmid, Sheryl & Fergusson, D & Mazzarello, Sasha & Hutton, Brian & Joy, A & McInnes, M & Clemons, M. (2018). Perceptions of vascular access for intravenous systemic therapy and risk factors for lymphedema in early-stage breast cancer-a patient survey. Current oncology (Toronto, Ont.). 25. e305-e310. McGee, S.F. & Mazzarello, Sasha & Caudrelier, Jean-Michel & Lima, M.A.G. & Hutton, Brian & Sienkiewicz, M. & Stober, C. & Fernandes, Roland & Ibrahim, Mohammed & Vandermeer, L. & Hilton, J. & Shorr, Risa & Fergusson, D. & Clemons, M.. (2018). Optimal Sequence of Adjuvant Endocrine and Radiation Therapy in Early-Stage Breast Cancer –† A Systematic Review. Cancer Treatment Reviews. 69. Fernandes, Roland & Mazzarello, Sasha & Joy, A. & Pond, Gregory & Hilton, J. & Ibrahim, Mohammed & Canil, C. & Ong, Michael & Stober, C. & Vandermeer, L. & Hutton, Brian & Costa, M. & Damaraju, Sambasivarao & Clemons, Mark. (2018). Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study. Supportive Care in Cancer. 26. Ibrahim, Mohammed & Hilton, John & Mazzarello, Sasha & Fergusson, Dean & Hutton, Brian & Robinson, Andrew & Califaretti, Nadia & Hsu, Tina & Gertler, Stan & Mates, Mihaela & Stober, Carol & Vandermeer, Lisa & Mallick, Ranjeeta & Clemons, Mark. (2017). A multi-center pragmatic, randomized, feasibility trial comparing standard of care schedules of filgrastim administration for primary febrile neutropenia prophylaxis in early-stage breast cancer. Breast Cancer Research and Treatment. 168. Jacobs, Carmel & Clemons, Mark & Mazzarello, Sasha & Hutton, Brian & Joy, Anil & Brackstone, Muriel & Freedman, Orit & Vandermeer, Lisa & Ibrahim, Mohammed & Fergusson, Dean & Hilton, John. (2017). Enhancing accrual to chemotherapy trials for patients with early stage triple-negative breast cancer: a survey of physicians and patients. Supportive Care in Cancer. 25. Fernandes, Ricardo & Mazzarello, Sasha & Stober, Carol & Vandermeer, Lisa & Dudani, Shaan & Ibrahim, Mohammed & Majeed, Habeeb & Perdrizet, Kirstin & Shorr, Risa & Hutton, Brian & Fergusson, Dean & Clemons, Mark. (2016). Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel–†cyclophosphamide chemotherapy for breast cancer: a systematic review. Breast Cancer Research and Treatment. 161.


Head And Neck Cancer, Thyroid Cancer, Breast Cancer, Gastrointestinal (GI) Cancer, Urethral Cancer, Muscoskeletal Sarcoma.